Sera Prognostics Inc. (SERA)

NASDAQ: SERA · Real-Time Price · USD

2.94

0.00 (0.00%)

At close: May 01, 2025, 3:59 PM

2.92

-0.68%

After-hours: May 01, 2025, 07:56 PM EDT

0.00% (1D)

Bid	2.91
Market Cap	107.9M
Revenue (ttm)	77K
Net Income (ttm)	-32.9M
EPS (ttm)	-0.99
PE Ratio (ttm)	-2.97
Forward PE	-3.02
Analyst	n/a

Ask	2.95
Volume	64,493
Avg. Volume (20D)	115,204
Open	2.92
Previous Close	2.94
Day's Range	2.88 - 3.04
52-Week Range	2.88 - 11.05
Beta	0.97

About SERA

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, g...

Sector Healthcare

IPO Date Jul 15, 2021

Employees 63

Stock Exchange NASDAQ

Ticker Symbol SERA

Website https://seraprognostics.com

Full Company Profile

Next Earnings Release

Sera Prognostics Inc. is scheduled to release its earnings on May 7, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 months ago

-9.44%

Sera Prognostics shares are trading lower after th... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

Sera Prognostics Inc (SERA) Q4 2024 Earnings Call Transcript

Sera Prognostics Inc (NASDAQ:SERA ) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director ...

1 month ago · zacks.com

Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates

Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.25 per share a year ago.